James Huang

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Comparison of patterns of relapse in thymic carcinoma and thymoma
    James Huang
    Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Thorac Cardiovasc Surg 138:26-31. 2009
  2. ncbi request reprint Feasibility of multimodality therapy including extended resections in stage IVA thymoma
    James Huang
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Thorac Cardiovasc Surg 134:1477-83; discussion 1483-4. 2007
  3. doi request reprint Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer
    Raja M Flores
    Division of Thoracic Surgery, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Thorac Cardiovasc Surg 141:59-64. 2011
  4. doi request reprint Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage
    Carole A Ridge
    1 Department of Radiology, Memorial Sloan Kettering Cancer Center, Box 29, 1275 York Ave, New York, NY 10065
    AJR Am J Roentgenol 201:959-63. 2013
  5. doi request reprint Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance
    Feiran Lou
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Thorac Cardiovasc Surg 145:75-81; discussion 81-2. 2013
  6. doi request reprint Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications
    Raja M Flores
    Division of Thoracic Surgery, Mount Sinai School of Medicine, New York, NY, USA
    J Thorac Cardiovasc Surg 142:1412-7. 2011
  7. pmc Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Helena A Yu
    Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA
    J Thorac Oncol 8:346-51. 2013
  8. pmc Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung
    Jamie E Chaft
    Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA
    J Thorac Oncol 7:1400-5. 2012
  9. doi request reprint Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance
    Feiran Lou
    Department of Surgery, SUNY Downstate Medical Center, Brooklyn, New York
    Ann Thorac Surg 96:1156-62. 2013
  10. ncbi request reprint Distinguishing benign thymic lesions from early-stage thymic malignancies on computed tomography
    Aoife McErlean
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Thorac Oncol 8:967-73. 2013

Collaborators

Detail Information

Publications22

  1. ncbi request reprint Comparison of patterns of relapse in thymic carcinoma and thymoma
    James Huang
    Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Thorac Cardiovasc Surg 138:26-31. 2009
    ..We reviewed our recent experience with the surgical management of thymic tumors and compared the outcomes and patterns of relapse between patients with thymic carcinoma and those with thymoma...
  2. ncbi request reprint Feasibility of multimodality therapy including extended resections in stage IVA thymoma
    James Huang
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Thorac Cardiovasc Surg 134:1477-83; discussion 1483-4. 2007
    ..We reviewed our experience with multimodality treatment for Masaoka stage IVA thymomas for feasibility and outcomes...
  3. doi request reprint Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer
    Raja M Flores
    Division of Thoracic Surgery, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Thorac Cardiovasc Surg 141:59-64. 2011
    ..In response, we investigated the pattern of recurrent disease and the incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery and thoracotomy...
  4. doi request reprint Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage
    Carole A Ridge
    1 Department of Radiology, Memorial Sloan Kettering Cancer Center, Box 29, 1275 York Ave, New York, NY 10065
    AJR Am J Roentgenol 201:959-63. 2013
    ..The purpose of this study was to compare measurements of lung tumor size between axial and multiplanar reformatted CT images, as well as to establish whether the difference between these measurements leads to a change in T stage...
  5. doi request reprint Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance
    Feiran Lou
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Thorac Cardiovasc Surg 145:75-81; discussion 81-2. 2013
    ....
  6. doi request reprint Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications
    Raja M Flores
    Division of Thoracic Surgery, Mount Sinai School of Medicine, New York, NY, USA
    J Thorac Cardiovasc Surg 142:1412-7. 2011
    ..We reviewed our experience to determine the frequency, management, and outcome of these complications...
  7. pmc Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Helena A Yu
    Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA
    J Thorac Oncol 8:346-51. 2013
    ..Metastasectomy is used in other cancers to manage oligometastatic disease. We hypothesized that local therapy is associated with improved outcomes in patients with EGFR-mutant lung cancers with acquired resistance to EGFR TKI...
  8. pmc Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung
    Jamie E Chaft
    Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA
    J Thorac Oncol 7:1400-5. 2012
    ..We sought to determine the effect of perioperative chemotherapy in patients with completely resected sarcomatoid carcinomas of the lung...
  9. doi request reprint Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance
    Feiran Lou
    Department of Surgery, SUNY Downstate Medical Center, Brooklyn, New York
    Ann Thorac Surg 96:1156-62. 2013
    ..Our goal was to determine the patterns of relapse and the manner of detection of recurrences, to guide follow-up care after resection...
  10. ncbi request reprint Distinguishing benign thymic lesions from early-stage thymic malignancies on computed tomography
    Aoife McErlean
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Thorac Oncol 8:967-73. 2013
    ..The purpose of this study is to identify CT features that distinguish benign thymic lesions from early-stage malignant thymic neoplasms...
  11. doi request reprint Combined thoracoscopic and laparoscopic robotic-assisted minimally invasive esophagectomy using a four-arm platform: experience, technique and cautions during early procedure development
    Inderpal S Sarkaria
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur J Cardiothorac Surg 43:e107-15. 2013
    ....
  12. doi request reprint Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability
    Patrick L Wagner
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Thorac Cardiovasc Surg 141:34-8. 2011
    ..This study examines paradoxical hemodynamic instability after pericardial window and identifies prognostic factors in patients with cancer who are treated for pericardial effusion...
  13. pmc Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas
    Nicolas Girard
    Human Oncology and Pathogenesis Program HOPP, Weill Medical College of Cornell University, New York, New York, USA
    Clin Cancer Res 15:6790-9. 2009
    ..However, whether the underlying biology of these tumors warrants such clustering is unclear, and the optimum treatment of either entity is unknown...
  14. doi request reprint Induction therapy for locally advanced thymoma
    Gregory J Riely
    Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Thorac Oncol 5:S323-6. 2010
    ..In this review, we summarize the published experience with preoperative therapy for thymoma and discuss ongoing clinical trials exploring multimodality therapy for treatment of locally advanced thymoma...
  15. ncbi request reprint Standard outcome measures for thymic malignancies
    James Huang
    Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine and Department of Biostatistics, School of Epidemiology and Public Health, Yale University, New Haven, Connecticut Thoracic Service, Memorial Sloan Kettering Cancer Center, New York City, New York and HH Gregg Professor of Oncology, Division of Medical Oncology, Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana
    J Thorac Oncol 6:S1691-7. 2011
    ..Widespread adoption of this baseline will enhance the ability to compare results from different series...
  16. doi request reprint The role of fine needle aspiration cytology in the diagnosis and management of thymic neoplasia
    Maureen F Zakowski
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA
    J Thorac Oncol 5:S281-5. 2010
    ..We show that needle aspiration sampling of thymic tumors, both thymoma and thymic carcinoma, is an accurate method of diagnosis...
  17. doi request reprint Management and outcomes of relapse after treatment for thymoma and thymic carcinoma
    Matthew J Bott
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Ann Thorac Surg 92:1984-91; discussion 1991-2. 2011
    ..Although surgery is the mainstay of treatment for thymic tumors, recurrence is common despite resection. The optimal approach to the management of disease relapse after treatment for thymic tumors remains unclear...
  18. ncbi request reprint Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopy
    Hangjun Wang
    From the Departments of Pathology Drs Wang and Moreira, Epidemiology and Biostatistics Dr Sima, and Surgery Dr Huang, Memorial Sloan Kettering Cancer Center, New York, New York the Department of Pathology, Mount Sinai School of Medicine, New York, New York Dr Beasley the Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland Dr Illei the Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York Dr Saqi The Christie Hospital, and School of Cancer and Enabling Sciences, Department of Histopathology, University of Manchester School of Medicine, Manchester, United Kingdom Dr Nonaka and the Department of Pathology and Laboratory Medicine, University of North Carolina Chapel Hill, Chapel Hill Dr Geisinger
    Arch Pathol Lab Med 138:658-63. 2014
    ..This technology could be used to train pathologists with low-level experience in thymic epithelial tumors and to foster collaborative work in the field. ..
  19. ncbi request reprint Preoperative computed tomography findings predict surgical resectability of thymoma
    Sara A Hayes
    Department of Radiology, Memorial Sloan Kettering Cancer Center Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center Department of Radiology, Weill Cornell Medical College New York Presbyterian Hospital and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
    J Thorac Oncol 9:1023-30. 2014
    ..The aim of the study was to identify preoperative computed tomography (CT) imaging characteristics that correlated with surgical resectability...
  20. doi request reprint Recurrence patterns after resection of soft tissue sarcomas of the chest wall
    Robert R McMillan
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    Ann Thorac Surg 96:1223-8. 2013
    ..Although some series have examined prognostic factors for survival with this rare set of neoplasms, our knowledge of the patterns of relapse is limited...
  21. doi request reprint Standard outcome measures for thymic malignancies
    James Huang
    Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine, Yale University, New Haven, Connecticut, USA
    J Thorac Oncol 5:2017-23. 2010
    ..Widespread adoption of this baseline will enhance the ability to compare results from different series...
  22. doi request reprint Failure patterns relative to radiation treatment fields for stage II-IV thymoma
    Andreas Rimner
    Departments of Radiation Oncology, Thoracic Surgery, Thoracic Oncology, Pathology, Epidemiology and Biostatistics, and Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York Departments of Radiation Oncology and Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas and Department of Radiation Oncology, Mt Sinai Medical Center, New York, New York
    J Thorac Oncol 9:403-9. 2014
    ..Here we report the failure patterns in stage II-IV thymoma after RT at two tertiary referral centers, classified according to the new International Thymic Malignancy Interest Group definitions...